• Home
  • About IBT
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Pipeline
    • IBP-9414
    • IBP-1016
    • IBP-1118
    • IBP-1122
    • Expanded Access Policy for Investigational Drugs
  • Healthcare Professionals
  • Investors & Media
    • Shares
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • Investors & Media Contact
  • Contact Us
  • Career
IBT Logo IBT Logo
  • En
  • Sv
  • Home
  • About IBT
    • IBT History
    • Management
    • Board of Directors
    • Advisory Board
    • Sustainability Policy
  • Pipeline
    • IBP-9414
    • IBP-1016
    • IBP-1118
    • IBP-1122
    • Expanded Access Policy for Investigational Drugs
  • Healthcare Professionals
  • Investors & Media
    • Shares
    • Share Issue
    • Ownership Structure
    • Corporate Governance
    • Calendar
    • Financial Reports
    • Press Releases
    • Investors & Media Contact
  • Contact Us
  • Career


Anthon Jahreskog
June 22, 2017

Latest press releases

2026-05-07 17:15 Annual General Meeting of Infant Bacterial Therapeutics Regulatory
2026-05-06 14:00 Infant Bacterial Therapeutics AB (publ) Interim report January 1 – March 31, 2026 Regulatory
2026-04-02 09:15 Correction: Notice of Annual General Meeting of Infant Bacterial Therapeutics Regulatory
2026-03-30 14:30 Notice of Annual General Meeting of Infant Bacterial Therapeutics Regulatory
2026-03-27 07:30 Infant Bacterial Therapeutics AB publishes the Annual Report for 2025 Regulatory
Contact | info@ibtherapeutics.com
© Copyright Infant Bacterial Therapeutics AB 2026
Cookie Policy Privacy Policy Terms of Use